XML 30 R20.htm IDEA: XBRL DOCUMENT
v3.22.0.1

STOCK BASED COMPENSATION (Tables) | 3 Months Ended
--- | ---
Jan. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
SCHEDULE OF OPTION ACTIVITY | SCHEDULE OF OPTION ACTIVITY
|  | Shares |  |  | Weighted Average Exercise Price Per Share |  |  | Aggregate Intrinsic Value (in thousands) |
Options outstanding at October 31, 2021 |  |  | 1,642,000 |  |  | $ | 2.58 |  |  |  |  |
Options outstanding and exercisable at January 31, 2022 |  |  | 1,642,000 |  |  | $ | 2.58 |  |  | $ | 1,158 |
Information regarding stock options that were granted outside of share plans for the three months ended January 31, 2021 is as follows:
|  | Shares |  |  | Weighted Average Exercise Price Per Share |  |  | Aggregate Intrinsic Value (in thousands) |
Options outstanding at October 31, 2020 |  |  | 1,698,000 |  |  | $ | 2.58 |  |  |  |  |
Options outstanding and exercisable at January 31, 2021 |  |  | 1,698,000 |  |  | $ | 2.58 |  |  | $ | 1,825 |
SCHEDULE OF OUTSTANDING AND EXERCISABLE | SCHEDULE OF OUTSTANDING AND EXERCISABLE
Range of Exercise Prices |  |  | Number Outstanding and Exercisable |  |  | Weighted Average Remaining Contractual Life (in years) |  |  | Weighted Average Exercise Price |
$ | 2.58 |  |  |  | 1,642,000 |  |  |  | 0.6 |  |  | $ | 2.58 |
The following table summarizes information about stock options outstanding and exercisable that were granted outside of share plans as of January 31, 2021:
Range of Exercise Prices |  |  | Number Outstanding and Exercisable |  |  | Weighted Average Remaining Contractual Life (in years) |  |  | Weighted Average Exercise Price |
$ | 2.58 |  |  |  | 1,698,000 |  |  |  | 1.6 |  |  | $ | 2.58 |
2010 Share Plan [Member] |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
SCHEDULE OF OPTION ACTIVITY | SCHEDULE OF OPTION ACTIVITY
|  | Shares |  |  | Weighted Average Exercise Price Per Share |  |  | Aggregate Intrinsic Value (in thousands) |
Options outstanding at October 31, 2021 |  |  | 1,718,634 |  |  | $ | 2.82 |  |  |  |  |
Granted |  |  | - |  |  | $ | - |  |  |  |  |
Exercised |  |  | (100,000 | ) |  | $ | 2.92 |  |  |  |  |
Forfeited/Expired |  |  | - |  |  | $ | - |  |  |  |  |
Options outstanding and exercisable at January 31, 2022 |  |  | 1,618,634 |  |  | $ | 2.81 |  |  | $ | 1,216 |
Options Outstanding |  |  | - |  |  | $ | - |  |  | $ | - |
Options Exercisable |  |  | - |  |  | $ | - |  |  | $ | - |
Information regarding the 2010 Share Plan for the three months ended January 31, 2021 is as follows:
|  | Shares |  |  | Weighted Average Exercise Price Per Share |  |  | Aggregate Intrinsic Value (in thousands) |
Options Outstanding at October 31, 2020 |  |  | 1,907,534 |  |  | $ | 2.82 |  |  |  |  |
Exercised |  |  | (6,000 | ) |  | $ | 2.32 |  |  |  |  |
Forfeited/Expired |  |  | (400 | ) |  | $ | 5.75 |  |  |  |  |
Options Outstanding at January 31, 2021 |  |  | 1,901,134 |  |  | $ | 2.82 |  |  | $ | 1,906 |
Options Exercisable at January 31, 2021 |  |  | 1,823,634 |  |  | $ | 2.83 |  |  | $ | 1,822 |
SCHEDULE OF OUTSTANDING AND EXERCISABLE | The following table summarizes information about stock options outstanding and exercisable under the 2010 Share Plan as of January 31, 2022: SCHEDULE OF OUTSTANDING AND EXERCISABLE
Range of Exercise Prices |  |  | Number Outstanding and Exercisable |  |  | Weighted Average Remaining Contractual Life (in years) |  |  | Weighted Average Exercise Price |
$ | 0.67 - $2.30 |  |  |  | 527,500 |  |  |  | 4.3 |  |  | $ | 1.54 |
$ | 2.58 - $3.13 |  |  |  | 577,000 |  |  |  | 2.9 |  |  | $ | 2.76 |
$ | 3.46 - $5.30 |  |  |  | 514,134 |  |  |  | 6.2 |  |  | $ | 4.16 |
The following table summarizes information about stock options outstanding and exercisable under the 2010 Share Plan as of January 31, 2021:
|  |  | Options Outstanding |  | Options Exercisable
| Range of Exercise Prices |  |  | Number Outstanding |  |  |  | Weighted Average Remaining Contractual Life (in years) |  |  |  | Weighted Average Exercise Price |  |  |  | Number Exercisable |  |  |  | Weighted Average Remaining Contractual Life (in years) |  |  | Weighted Average Exercise Price
$ | 0.67 - $2.30 |  |  | 544,000 |  |  |  | 5.2 |  |  | $ | 1.56 |  |  |  | 516,500 |  |  |  | 5.2 |  |  | $ | 1.60
$ | 2.58 - $ 3.13 |  |  | 833,000 |  |  |  | 3.1 |  |  | $ | 2.79 |  |  |  | 833,000 |  |  |  | 3.5 |  |  | $ | 2.79
$ | 3.46 - $ 5.30 |  |  | 524,134 |  |  |  | 7.1 |  |  | $ | 4.17 |  |  |  | 474,134 |  |  |  | 7.1 |  |  | $ | 4.25
2018 Share Plan [Member] |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
SCHEDULE OF OPTION ACTIVITY | SCHEDULE OF OPTION ACTIVITY
|  | Shares |  |  | Weighted Average Exercise Price Per Share |  |  | Aggregate Intrinsic Value (in thousands) |
Options outstanding at October 31, 2021 |  |  | 7,409,992 |  |  | $ | 3.76 |  |  |  |  |
Granted |  |  | 30,000 |  |  | $ | 3.24 |  |  |  |  |
Options outstanding at January 31, 2022 |  |  | 7,439,992 |  |  | $ | 3.76 |  |  | $ | 676 |
Options exercisable at January 31, 2022 |  |  | 3,986,659 |  |  | $ | 3.66 |  |  | $ | 347 |
Information regarding the 2018 Share Plan for the three months ended January 31, 2021 is as follows:
|  | Shares |  |  | Weighted Average Exercise Price Per Share |  |  | Aggregate Intrinsic Value (in thousands) |
Options outstanding at October 31, 2020 |  |  | 4,346,661 |  |  | $ | 3.69 |  |  |  |  |
Granted |  |  | 1,130,000 |  |  | $ | 2.83 |  |  |  |  |
Exercised |  |  | (23,880 | ) |  | $ | 3.78 |  |  |  |  |
Forfeited/Expired |  |  | (392,781 | ) |  | $ | 3.70 |  |  |  |  |
Options outstanding at January 31, 2021 |  |  | 5,060,000 |  |  | $ | 3.49 |  |  | $ | 1,185 |
Options exercisable at January 31, 2021 |  |  | 2,312,640 |  |  | $ | 3.69 |  |  | $ | 148 |
SCHEDULE OF OUTSTANDING AND EXERCISABLE | The following table summarizes information about stock options outstanding and exercisable under the 2018 Share Plan as of January 31, 2022: SCHEDULE OF OUTSTANDING AND EXERCISABLE
|  |  | Options Outstanding |  |  | Options Exercisable |
| Range of Exercise Prices |  |  |  | Number Outstanding |  |  |  | Weighted Average Remaining Contractual Life (in years) |  |  |  | Weighted Average Exercise Price |  |  |  | Number Exercisable |  |  |  | Weighted Average Remaining Contractual Life (in years) |  |  |  | Weighted Average Exercise Price |
$ | 2.09 - $3.87 |  |  |  | 3,969,992 |  |  |  | 7.5 |  |  | $ | 3.42 |  |  |  | 3,030,548 |  |  |  | 7.1 |  |  | $ | 3.53 |
$ | 3.96 - $5.30 |  |  |  | 3,470,000 |  |  |  | 8.7 |  |  | $ | 4.16 |  |  |  | 956,111 |  |  |  | 7.8 |  |  | $ | 4.08 |
The following table summarizes information about stock options outstanding and exercisable under the 2018 Share Plan as of January 31, 2021:
|  |  | Options Outstanding |  |  | Options Exercisable |
| Range of Exercise Prices |  |  |  | Number Outstanding |  |  |  | Weighted Average Remaining Contractual Life (in years) |  |  |  | Weighted Average Exercise Price |  |  |  | Number Exercisable |  |  |  | Weighted Average Remaining Contractual Life (in years) |  |  |  | Weighted Average Exercise Price |
$ | 2.09 - $3.70 |  |  |  | 3,975,000 |  |  |  | 8.1 |  |  | $ | 3.38 |  |  |  | 1,664,862 |  |  |  | 7.5 |  |  | $ | 3.61 |
$ | 3.84 - $4.61 |  |  |  | 1,085,000 |  |  |  | 8.0 |  |  | $ | 3.90 |  |  |  | 647,778 |  |  |  | 7.7 |  |  | $ | 3.92 |

X
- Definition Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (d) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_PlanNameAxis=ANIX_TwoThousandTenPlanMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_PlanNameAxis=ANIX_TwoThousandEighteenPlanMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |